Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

HCA Holdings Inc. buy UBS Group AG

Start price
€337.30
14.08.24 / 50%
Target price
€396.96
14.08.25
Performance (%)
0.33%
End price
€338.40
15.08.25
Summary
This prediction ended on 15.08.25 with a price of €338.40. During the runtime of the prediction for HCA Holdings Inc. the price only changed by 0.33%. A total of €1.94 was paid as dividends for this prediction. UBS_Group_AG has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
HCA Holdings Inc. 0.274% 0.274% 37.014%
iShares Core DAX® -1.212% 1.925% 17.589%
iShares Nasdaq 100 -4.714% -1.810% 0.450%
iShares Nikkei 225® -2.976% -2.660% 10.156%
iShares S&P 500 -2.744% -0.448% 0.320%

Comments by UBS_Group_AG for this prediction

In the thread HCA Holdings Inc. diskutieren
Prediction Buy
Perf. (%) 0.33%
Target price 396.959
Change
Ends at 14.08.25

HCA Healthcare, Inc. (NYSE: HCA) had its price target raised by analysts at UBS Group AG from $405.00 to $438.00. They now have a "buy" rating on the stock.
Ratings data for HCA provided by MarketBeat

In the thread Trading HCA Holdings Inc.
Prediction Buy
Perf. (%) 0.33%
Target price 396.959
Change
Ends at 14.08.25

Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten